NSE IPO - Apply Online, Check Issue Date, Price, Lot Size & Allotment Status

Apply for NSE IPO:

Skip to main content

Live Ardelyx, Inc. Share Price Chart

O H L

Ardelyx, Inc. Performance Overview

Days Range
$3.35Low
$3.38High

Markets Today

Previous Close$3.38
Open$3.37
Volume503,541
Day's Range$3.35 - $3.38
52W Range$3.34 - $8.40
Market Cap$875.26 M

Historical Performance

1M Returns-13.78
3M Returns-44.13
6M Returns-39.10
1Y Returns-47.35
5Y Returns+158.02
10Y Returns-69.88

Ardelyx, Inc. Fundamentals

Market Cap$875.26 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$407.32 M
ROE TTM-0.36
EPS TTM$-0.23
Quarterly Earnings Growth YOYN/A
PB Ratio5.67
EBITDA$-37.92 M
Profit Margin-15.12
Market Cap$875.26 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$407.32 M
ROE TTM-0.36
EPS TTM$-0.23
Quarterly Earnings Growth YOYN/A
PB Ratio5.67
EBITDA$-37.92 M
Profit Margin-15.12

Ardelyx, Inc. Profit & Loss

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Total Revenue +$74.11 M$97.66 M$110.33 M$125.22 M$94.47 M$120.88 M
Gross Profit +$61.81 M$85.26 M$106.35 M$114.37 M$89.66 M$115.12 M
Operating Income -$36.35 M-$14.39 M$4.67 M$5.10 M-$32.79 M-$12.43 M
EBITDA -$35.75 M-$13.76 M$5.57 M$6.02 M-$31.88 M-$11.82 M
Interest Expense -$6.26 M-$6.58 M-$7.98 M$719.00 K-$6.92 M-$6.22 M
Depreciation $602.00 K$631.00 K$905.00 K$921.00 K$915.00 K$604.00 K
Income Before Tax -$40.28 M-$19.08 M-$867.00 K-$400.00 K-$37.60 M-$16.61 M
Income Tax Expense $859.00 K$1.00 K$102.00 K$7.00 K$8.00 K$110.00 K
Net Income +-$41.14 M-$19.08 M-$969.00 K-$407.00 K-$37.60 M-$16.72 M
Net Profit Margin -55.51%-19.54%-0.88%-0.33%-39.81%-13.83%

Ardelyx, Inc. Financials Balance Sheet In USD

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Share Capital $24.00 K$24.00 K$24.00 K$24.00 K$25.00 K$25.00 K
Reserve & Surplus -$926.47 M-$945.60 M-$946.41 M-$946.74 M-$984.67 M-$1.00 B
Non-Current Liabilities $188.68 M$245.52 M$248.50 M$246.05 M$246.32 M$294.66 M
Current Liabilities $75.84 M$81.72 M$83.39 M$88.61 M$109.57 M$132.22 M
Total Liabilities $264.52 M$327.24 M$331.89 M$334.65 M$355.88 M$426.88 M
Fixed Assets $1.67 M$2.14 M$2.07 M$2.18 M$2.00 M$1.78 M
Current Assets $312.69 M$351.57 M$367.99 M$382.32 M$381.87 M$441.93 M
Total Assets $410.19 M$466.77 M$486.17 M$501.60 M$504.51 M$575.89 M

Ardelyx, Inc. Cash Flow

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Net Income -$41.14 M-$19.08 M-$969.00 K-$407.00 K-$37.60 M-$16.72 M
Operating Cash Flow -$38.46 M-$25.34 M$365.00 K$20.95 M-$32.24 M-$6.40 M
Investing Cash Flow $2.85 M$34.92 M-$50.51 M$3.78 M-$9.99 M$22.66 M
Financing Cash Flow $1.48 M$49.66 M$2.81 M$557.00 K$5.44 M$49.72 M
Change in Cash -$34.12 M$59.24 M-$47.33 M$25.28 M-$36.79 M$65.98 M

Ardelyx, Inc. Return Calculator

The Ardelyx, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$25,573
Invested Amount$10,000
Est. Returns$15,573
Invest in USA Stock Today

About Ardelyx, Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

FAQs

Ardelyx, Inc. (ARDX) share price as of September 18, 2026 is $3.35. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Ardelyx, Inc. (ARDX) Share by opening an international trading account with Angel One.
Purchasing Ardelyx, Inc. (ARDX) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Ardelyx, Inc. (ARDX) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Ardelyx, Inc. (ARDX) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Ardelyx, Inc. on September 18, 2026, is $875.26 M.
Ardelyx, Inc. operates in the Healthcare sector, specifically in the Healthcare industry.
In order to invest in Ardelyx, Inc. (ARDX) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Top US Stocks

VIEW ALL

Open Free Demat Account!

Join our 3.8 Cr+ happy customers
+91